Dermatology
Latest News
Novel analysis quantifies the benefit of melanoma screening
“Further studies are needed to determine whether individuals without a family history of melanoma may benefit from whole-body screening, and...
Conference Coverage
Oral sarecycline promising for papulopustular rosacea
“Always aim for clear skin.”
Conference Coverage
National Psoriasis Foundation recommends some stop methotrexate for 2 weeks after J&J vaccine
The rationale is to optimize the antibody response to the killed-adenovirus COVID-19 vaccine.
Conference Coverage
Contact dermatitis content varies among social media sites
The hashtag #contactdermatitis is the most used overall, but #AllergicContactDermatitis is more popular among physicians.
Conference Coverage
Check all components in cases of suspected shoe allergy
Approximately 30% of patch tested patients with shoe allergies reacted to supplemental allergens.
Conference Coverage
Will psoriasis patients embrace proactive topical therapy?
Results of year-long PSO-LONG trial show superior efficacy, compared with conventional reactive management.
Conference Coverage
Contact allergen of the year found in foam in shin guards, footwear
The compound is likely not added intentionally, but is thought to result from reactions between additives during the manufacturing process.
From the Journals
Itch response faster with abrocitinib in trial comparing JAK inhibitor to dupilumab
At 2 weeks, half of the patients on 200 mg of abrocitinib had an itch response.
From the Journals
Vasodilatory medications found protective against rosacea
“We were very surprised to find that many of the agents we think of as vasodilators might actually be beneficial for rosacea.”
From the Journals
Is it possible to classify dermatologists and internists into different patterns of prescribing behavior?
“Future work is needed to identify underlying factors associated with different prescribing phenotypes among both dermatologists and internists...
From the Journals
Bacteriotherapy passes early test in phase 1 atopic dermatitis study
ShA9, a bacterium isolated from healthy human skin, was chosen as a potential topical therapy for AD based on its capacity both to...